🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety of a protocol which doe...
Status
Completed
Location
Heart Institute of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start Date
2017-05-03
Trial ID
NCT03181386
Treatments Being Tested
The study will evaluate the incidence of major bleeding (including clinical...
Status
Completed
Location
University of Southern California Keck School of Medicine
Start Date
2015-04-28
Trial ID
NCT02366871
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetics of a single ora...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01340586
Atrial fibrillation (AF) is a prevalent and serious disease in hemodialysis...
Status
Completed
Location
Carolina Polo
Start Date
2021-05-20
Trial ID
NCT04952792
Treatments Being Tested
The purpose of the study is to describe the safety and efficacy outcomes of...
Status
Unknown
Location
Rawalpindi Medical University
Start Date
2022-03-01
Trial ID
NCT05088928
Treatments Being Tested
The Study is an open-labeled, randomized controlled trial, phase IIIb. Its ...
Status
Completed
Location
Universitätsklinikum Münster
Start Date
2017-06-20
Trial ID
NCT02933697
Treatments Being Tested
The purpose of this study is to learn whether apixaban prevents the develop...
Status
Completed
Location
Local Institution
Start Date
2007-06
Trial ID
NCT00452530
Treatments Being Tested
This study was to compare the study drug BAY1213790 to existing therapies, ...
Status
Completed
Location
UMHAT Sveti Georgi
Start Date
2017-09-21
Trial ID
NCT03276143
Treatments Being Tested
In renally impaired patients with acute venous thromboembolism (VTE), stand...
Status
Terminated
Location
CH ARRAS
Start Date
2016-10-19
Trial ID
NCT02664155
Treatments Being Tested
This was an open-label, randomized, single-dose, two-period, two-sequence, ...
Status
Completed
Location
PT Equilab International
Start Date
2021-04-15
Trial ID
NCT06817811